Bharat Biotech Launches New Rotavirus Vaccine to Tackle Diarrhoea
Science & Technology
10th Dec, 2019
In order to effectively tackle the menace of diarrhea plaging developing economies including India, Hyderabad-based Bharat Biotech International has commercially launched Rotavac 5D, an oral rotavirus vaccine at virtually one-tenth the cost when compared to private hospitals.
- Rotovac 5D has been developed with close coordination with the Department of Biotechnology.
- Earlier, Bharat Biotech had originated ROTAVAC and now they have upgraded their already available oral vaccine to ROTAVAC 5D.
- The roll-out of oral rotavirus vaccine is also the lowest dose-volume rotavirus vaccine in the world.
- Along with the reduction in dosage, they have also made the oral vaccine low cold chain proof. This has resulted in making the vaccine stable at 2-degree to 8-degree Celsius for up to 24 months.
- Globally, rotavirus causes approximately 200,000 deaths and about 2 million hospitalizations annually, mostly in low-income countries.
- Currently, ROTAVAC 5D is being supplied in seven countries including India and 50 more countries have registered for it.
What is rotavirus?
- Rotavirus is a virus that infects the bowels, causing a severe inflammation of the stomach and bowels (known as gastroenteritis). It is a very contagious virus that causes diarrhea.
- Rotavirus is the most common cause of severe diarrhea among infants and children throughout the world and causes the death of about 500,000 children worldwide annually.
- The name rotavirus comes from the characteristic wheel-like appearance of the virus when viewed by electron microscopy.
Symptoms of rotavirus
- Black or tarry stools
- Stools with blood or pus in them
- Severe fatigue
- A high fever
- Abdominal pain
- Rotavirus is transmitted between hand and mouth contact. If you touch a person or object carrying the virus and then touch your mouth, you could develop the infection.
- Infants and children under 3 are at the highest risk for rotavirus infection.